Loading...
XBKK
WPH
Market cap134mUSD
Nov 12, Last price  
6.10THB
Name

Wattanapat Hospital Trang PCL

Chart & Performance

D1W1MN
XBKK:WPH chart
P/E
15.32
P/S
2.10
EPS
0.40
Div Yield, %
1.67%
Shrs. gr., 5y
1.70%
Rev. gr., 5y
21.92%
Revenues
2.03b
+39.23%
430,860,000476,540,000542,000,000533,312,823625,874,680754,467,429705,469,6061,226,292,7141,145,499,7011,459,610,7152,032,145,719
Net income
279m
+200.13%
-16,610,00043,470,00072,240,00024,191,80051,476,395-6,484,285-33,686,608232,291,830115,661,05492,909,565278,846,630
CFO
476m
+102.33%
79,340,00051,070,000111,670,00048,342,18677,838,44734,631,19831,539,20560,562,204408,423,380235,477,764476,437,920
Dividend
Mar 11, 20240.102 THB/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Wattanapat Hospital Trang Public Company Limited operates hospitals and clinics in Thailand. The company operates medical clinics, including obstetrics and gynecology, surgery, internal medicine, pediatric, neurology, cardiology, eye, ENT, skin and beauty, dental, and wellness center, as well as X-Ray and MRI center, WPH emergency center, emergency center, kidney clinic and hemodialysis center, physical therapy clinic, gastrointestinal clinic, orthopedic clinic, and diabetes thyroid and endocrinology. Wattanapat Hospital Trang Public Company Limited was founded in 1957 and is headquartered in Trang, Thailand.
IPO date
Oct 03, 2017
Employees
Domiciled in
TH
Incorporated in
TH

Valuation

Title
THB in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT